Target: A post approval study to evaluate targeted SCS (DRG) stimulation for the management of moderate to severe chronic, intractable, pain of the lower limbs due to CRPS types I and II,
Role: PI,
St. Jude Medical Inc.,
(08/2021 - 08/2022)
Status: Completed
Study to assess the safety of 3 mg/ml Gablofen® (Baclofen injection) delivered by intrathecal administration using the Synchromed® II programmable infusion system (CNS-GAB101US),
Role: Investigator,
Mallinckrodt Pharmaceuticals, Inc,
(09/2016 - 09/2017)
Status: Completed
Internal
Factors affecting outcomes in the use of high frequency spinal cord simulators in the treatment of back and leg pain,
Role: PI,
LLU Dept. of Physical Medicine & Rehab,
(07/2019)
Status: Approved
Non-Profit Organization
The effect of spirituality and stress-management on patient outcomes following illness related loss of functioning,
Role: Investigator,
Fetzer Foundation,
(03/1999 - 03/2000)
Status: Completed